MUSCULAR DYSTROPHY TREATED WITH NORETHANDROLONE

被引：24

作者：

DOWBEN, RM

PERLSTEIN, MA

机构：

来源：

ARCHIVES OF INTERNAL MEDICINE | 1961年 / 107卷 / 02期

关键词：

D O I：

10.1001/archinte.1961.03620020095009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：245 / &

共 20 条

[11] THE DETERMINATION OF CREATININE IN PLASMA OR SERUM, AND IN URINE - A CRITICAL EXAMINATION [J].

OWEN, JA ;

IGGO, B ;

SCANDRETT, FJ ;

STEWART, CP .

BIOCHEMICAL JOURNAL, 1954, 58 (03) :426-437

[12] MYOTROPHIC AND ANDROGENIC EFFECTS OF 17-ETHYL-19-NORTESTOSTERONE AND RELATED COMPOUNDS [J].

SAUNDERS, FJ ;

DRILL, VA .

ENDOCRINOLOGY, 1956, 58 (05) :567-572

[13] CHOLESTASIS PRODUCED BY THE ADMINISTRATION OF NORETHANDROLONE [J].

SCHAFFNER, F ;

POPPER, H ;

CHESROW, E .

AMERICAN JOURNAL OF MEDICINE, 1959, 26 (02) :249-254

[14]

SCHAPIRA G, 1955, Am J Phys Med, V34, P313

[15]

STEINER MM, PRIV COMMUNICATIONS

[16]

SWINYARD C A, 1957, Arch Phys Med Rehabil, V38, P574

[17] SERUM ALDOLASE IN MUSCLE DISEASE [J].

THOMPSON, RA ;

VIGNOS, PJ .

ARCHIVES OF INTERNAL MEDICINE, 1959, 103 (04) :551-564

[18]

WESTON RE, 1956, J CLIN INVEST, V35, P744

[19]

WHITE AA, 1957, P SOC EXP BIOL MED, V94, P541

[20]

WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210

← 1 2 →